Swiss National Bank
BSX icon

Swiss National Bank’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$481M Buy
4,477,200
+320,400
+8% +$34.4M 0.29% 52
2025
Q1
$419M Sell
4,156,800
-3,400
-0.1% -$343K 0.3% 54
2024
Q4
$372M Sell
4,160,200
-203,400
-5% -$18.2M 0.25% 66
2024
Q3
$366M Buy
4,363,600
+11,600
+0.3% +$972K 0.24% 66
2024
Q2
$335M Sell
4,352,000
-35,200
-0.8% -$2.71M 0.23% 74
2024
Q1
$300M Sell
4,387,200
-191,500
-4% -$13.1M 0.21% 86
2023
Q4
$265M Sell
4,578,700
-45,600
-1% -$2.64M 0.19% 94
2023
Q3
$244M Sell
4,624,300
-566,800
-11% -$29.9M 0.19% 91
2023
Q2
$281M Sell
5,191,100
-493,200
-9% -$26.7M 0.19% 94
2023
Q1
$284M Sell
5,684,300
-134,100
-2% -$6.71M 0.19% 95
2022
Q4
$269M Sell
5,818,400
-376,980
-6% -$17.4M 0.19% 102
2022
Q3
$240M Buy
6,195,380
+6,500
+0.1% +$252K 0.17% 111
2022
Q2
$231M Buy
6,188,880
+16,900
+0.3% +$630K 0.16% 121
2022
Q1
$273M Buy
6,171,980
+760,000
+14% +$33.7M 0.15% 114
2021
Q4
$230M Sell
5,411,980
-211,100
-4% -$8.97M 0.14% 124
2021
Q3
$244M Sell
5,623,080
-155,500
-3% -$6.75M 0.16% 115
2021
Q2
$247M Buy
5,778,580
+49,555
+0.9% +$2.12M 0.15% 119
2021
Q1
$221M Buy
5,729,025
+106,800
+2% +$4.13M 0.15% 128
2020
Q4
$202M Sell
5,622,225
-145,000
-3% -$5.21M 0.14% 130
2020
Q3
$220M Buy
5,767,225
+39,300
+0.7% +$1.5M 0.17% 115
2020
Q2
$201M Buy
5,727,925
+107,600
+2% +$3.78M 0.17% 118
2020
Q1
$183M Buy
5,620,325
+1,042,500
+23% +$34M 0.19% 105
2019
Q4
$207M Sell
4,577,825
-452,700
-9% -$20.5M 0.21% 90
2019
Q3
$205M Sell
5,030,525
-36,805
-0.7% -$1.5M 0.22% 91
2019
Q2
$218M Sell
5,067,330
-129,400
-2% -$5.56M 0.23% 86
2019
Q1
$199M Buy
5,196,730
+11,400
+0.2% +$438K 0.22% 93
2018
Q4
$183M Buy
5,185,330
+76,000
+1% +$2.69M 0.24% 87
2018
Q3
$197M Sell
5,109,330
-159,900
-3% -$6.16M 0.22% 93
2018
Q2
$172M Buy
5,269,230
+142,200
+3% +$4.65M 0.2% 106
2018
Q1
$140M Sell
5,127,030
-562,900
-10% -$15.4M 0.17% 128
2017
Q4
$141M Buy
5,689,930
+31,200
+0.6% +$773K 0.15% 149
2017
Q3
$165M Buy
5,658,730
+73,800
+1% +$2.15M 0.19% 117
2017
Q2
$155M Buy
5,584,930
+156,800
+3% +$4.35M 0.18% 120
2017
Q1
$135M Buy
5,428,130
+1,070,700
+25% +$26.6M 0.17% 131
2016
Q4
$94.3M Buy
4,357,430
+602,500
+16% +$13M 0.15% 153
2016
Q3
$89.4M Sell
3,754,930
-24,700
-0.7% -$588K 0.14% 157
2016
Q2
$88.3M Buy
3,779,630
+284,800
+8% +$6.66M 0.14% 158
2016
Q1
$63M Buy
3,494,830
+1,053,100
+43% +$19M 0.12% 196
2015
Q4
$45M Buy
2,441,730
+49,400
+2% +$911K 0.11% 212
2015
Q3
$39.3M Buy
2,392,330
+245,700
+11% +$4.03M 0.1% 233
2015
Q2
$38M Buy
2,146,630
+125,900
+6% +$2.23M 0.1% 236
2015
Q1
$35.9M Buy
2,020,730
+788,200
+64% +$14M 0.1% 240
2014
Q4
$16.3M Sell
1,232,530
-35,900
-3% -$476K 0.06% 316
2014
Q3
$15M Sell
1,268,430
-22,200
-2% -$262K 0.06% 324
2014
Q2
$16.5M Sell
1,290,630
-3,600
-0.3% -$46K 0.06% 312
2014
Q1
$17.5M Sell
1,294,230
-134,400
-9% -$1.82M 0.07% 281
2013
Q4
$17.2M Sell
1,428,630
-32,400
-2% -$389K 0.07% 295
2013
Q3
$17.2M Buy
1,461,030
+16,500
+1% +$194K 0.07% 287
2013
Q2
$13.4M Buy
+1,444,530
New +$13.4M 0.06% 335